Clinical Trial: Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: EVALUATION CLINIQUE ET BIOLOGIQUE A LONG TERME DES PATIENTS ATTEINTS DE FORMES SEVERES DE PEMPHIGUS TRAITES PAR LE RITUXIMAB
Brief Summary: The purpose of this study is to study the midterm clinical evaluation, biological parameters and immune reconstitution after Rituximab treatment for Pemphigus.
Detailed Summary:
Sponsor: University Hospital, Rouen
Current Primary Outcome: Rate of relapse after 5 years of treatment [ Time Frame: five years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University Hospital, Rouen
Dates:
Date Received: February 17, 2011
Date Started: June 2011
Date Completion:
Last Updated: September 12, 2012
Last Verified: September 2012